公开(公告)号：US20050220243A1

公开(公告)日：2005-10-06

申请号：US10998188

申请日：2004-11-27

Applicant: Wilson Greatbatch

Inventor： Wilson Greatbatch

IPC: G21B1/00

CPC classification number: G21B1/00 ,  Y02E30/10

Abstract: An improved 3He nuclear reactor with provision for direct electric conversion of a relativistic proton stream into useable electric power at a voltage level compatible with the national power grid (one million V DC). Various embodiments include multiple collector cages for extracting relativistic protons of various energy levels, diverter wires for deflecting high-energy proton streams to either side of lower energy cages to avoid unwanted impact. Other embodiments include arrangements for dividing multi-megavolt voltages down to a useable one megavolt level compatible with the national power grid. Further embodiments comprise guiding the proton stream by the cusps of magnetron cavities to permit conversion of the relativistic proton energies into microwave power. A proposal is also made for harvesting 3He from the Moon to supply earth-bound and space-bound reactors. A solution to the problem of charging a potential well-forming anode in an electrostatic fusion reactor without electrical arcing is further disclosed.

Abstract translation: 提供了一种改进的“3”He核反应堆，提供了将相对论质子流直接电转换为与国家电网（一百万V DC）兼容的电压电平的可用电力。 各种实施例包括用于提取各种能级的相对论质子的多个收集器笼，用于将高能质子流偏转到较低能量笼的任一侧的分流线，以避免不必要的冲击。 其他实施例包括将多兆伏特电压分解为与国家电网兼容的可用的一兆瓦级的布置。 另外的实施例包括通过磁控管腔的尖端引导质子流，以允许相对论质子能量转换成微波功率。 还提出了从月球上采集他的“3”以提供地球和空间有限的反应堆的建议。 进一步公开了在没有电弧放电的静电聚变反应器中对潜在的成井阳极进行充电的问题的解决方案。

公开(公告)号：US06909915B2

公开(公告)日：2005-06-21

申请号：US10350921

申请日：2003-01-24

Applicant: Wilson Greatbatch ,  Jeffrey Deal

Inventor： Wilson Greatbatch ,  Jeffrey Deal

IPC: A61N1/08 ,  A61N1/378 ,  H01M6/16 ,  H01M6/50 ,  H01M10/052 ,  H01M16/00 ,  H02J7/00 ,  A61N1/40

CPC classification number: H01M16/00 ,  A61N1/08 ,  A61N1/378 ,  H01M6/16 ,  H01M6/5016 ,  H01M6/5033 ,  H01M10/052 ,  H02J7/0054

Abstract: A hybrid battery power source for implantable medical use provides relatively stable resistance during discharge and avoids the voltage delays that develop as a result of variable resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary battery of relatively high energy density and the other being a rechargeable secondary battery of low relatively stable internal resistance. The primary and secondary batteries are connected in a parallel arrangement, preferably via an intermediate voltage boost circuit having an inductor and a pulse generating control circuit therein. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven in whole or substantial part by the secondary battery. The primary battery is used to as an energy source for recharging the secondary battery. By arranging the two batteries in parallel, with one serving as a primary battery and the other as a rechargeable secondary battery, all the benefits of the defibrillatory impulse will be obtained and the deficiencies arising from variable voltage delay found in prior art implantable power sources will not be present.

Abstract translation: 用于可植入医疗用途的混合电池电源在放电期间提供相对稳定的电阻，并且避免由于Li / SVO电池中可变电阻增加而导致的电压延迟。 混合电池电源使用两个电池或电池，一个是相对较高能量密度的一次电池，另一个是具有低相对稳定内阻的可再充电二次电池。 主电池和二次电池以并联的方式连接，优选地经由其中具有电感器和脉冲发生控制电路的中压升压电路。 混合电池电源所在的医疗装置的储能电容器由二次电池全部或大部分驱动。 主电池用作为二次电池充电的能量源。 通过并联布置两个电池，一个充当一次电池，另一个作为可充电二次电池，将获得除颤脉冲的所有益处，并且在现有技术的可植入电源中发现的可变电压延迟引起的缺陷将会 不存在

公开(公告)号：US06795736B2

公开(公告)日：2004-09-21

申请号：US10077868

申请日：2002-02-19

Applicant: Patrick R. Connelly ,  Wilson Greatbatch ,  Victor Miller

Inventor： Patrick R. Connelly ,  Wilson Greatbatch ,  Victor Miller

IPC: A61N1362

CPC classification number: G01R33/285 ,  A61N1/056 ,  A61N1/086 ,  A61N1/3718 ,  A61N1/375 ,  G01R33/288

Abstract: An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.

公开(公告)号：US06795730B2

公开(公告)日：2004-09-21

申请号：US09839286

申请日：2001-04-20

Applicant: Patrick R. Connelly ,  Michael Weiner ,  Wilson Greatbatch

Inventor： Patrick R. Connelly ,  Michael Weiner ,  Wilson Greatbatch

IPC: A61N136

CPC classification number: A61N1/37 ,  A61N1/3718 ,  A61N1/375

Abstract: An implantable device used to monitor and maintain at least one physiologic function, which is capable of operating in the presence of damaging electromagnetic interference. The implantable device includes primary and secondary modules, each independently protected from EMI damage via at least one shielding and/or filtering, and a non-electrical communication device for communicating in at least one direction between the primary and the secondary modules. The primary module, in response to input from electrical sensing leads, activates the secondary module in a failsafe mode. In the failsafe mode, the secondary module carries out a physiologic function upon activation and in the presence of electromagnetic interference.

Abstract translation: 用于监测和保持至少一种生理功能的可植入装置，其能够在存在有害电磁干扰的情况下操作。 可植入装置包括主模块和次模块，每个模块通过至少一个屏蔽和/或滤波器独立地防止EMI损伤，以及用于在主模块和次模块之间的至少一个方向上进行通信的非电通信装置。 主模块响应于电气感测引线的输入，在故障安全模式下激活辅助模块。 在故障安全模式下，次级模块在激活时和存在电磁干扰的情况下执行生理功能。

公开(公告)号：US4050004A

公开(公告)日：1977-09-20

申请号：US429527

申请日：1974-01-02

Applicant: Wilson Greatbatch

Inventor： Wilson Greatbatch

IPC: A61N1/362 ,  A61N1/378 ,  B23K11/26 ,  H01S3/092 ,  H02M3/07 ,  H02M3/337 ,  H02M7/10 ,  H03K3/57 ,  H05B41/282 ,  H02M7/00

CPC classification number: A61N1/025 ,  A61N1/362 ,  A61N1/378 ,  B23K11/26 ,  H01S3/092 ,  H02M3/07 ,  H02M3/337 ,  H02M7/10 ,  H03K3/57 ,  H05B41/2821 ,  Y02B70/1433 ,  Y10T307/56 ,  Y10T307/713

Abstract: A cardiac pacer including a controlled voltage multiplier adapted for connection to a source of voltage to be multiplied and a plurality of parallel voltage-developing branches each including a capacitor. A pair of output terminals, at least one of which is adapted to be operatively connected to a patient's heart, are connected in series with one of the capacitors whereby the path for current charging that capacitor is through the load connected to the terminals. A corresponding plurality of controlled switches are connected to corresponding ones of the capacitors, and the switches and capacitors are connected together to define a series discharge path including the pair of output terminals when the switches are operated by a trigger pulse generator. Including timing means controlling the generation of pulses for triggering the controlled switches and thereby controlling the stimulating output pulses appearing on the pacer output terminals. The cardiac pacer can include regulating means for limiting the amplitude of the output pulses.

Abstract translation: 一种心脏起搏器，其包括适于连接到要倍增的电压源的受控电压倍增器和包括电容器的多个平行电压显影支路。 一对输出端子，其至少一个适于可操作地连接到患者的心脏，与电容器中的一个串联连接，由此电容器的电流充电路径通过连接到端子的负载。 相应的多个受控开关连接到对应的电容器中，并且当开关由触发脉冲发生器操作时，开关和电容器连接在一起以限定包括该对输出端子的串联放电路径。 包括定时装置控制用于触发受控开关的脉冲的产生，从而控制出现在起搏器输出端子上的刺激输出脉冲。 心脏起搏器可以包括用于限制输出脉冲的振幅的调节装置。

公开(公告)号：US20070217163A1

公开(公告)日：2007-09-20

申请号：US11376616

申请日：2006-03-15

Applicant: Wilson Greatbatch ,  Jeffrey Deal

Inventor： Wilson Greatbatch ,  Jeffrey Deal

IPC: H05K7/20

CPC classification number: A61N1/375 ,  A61N1/37211 ,  A61N1/3787

Abstract: An implantable device includes a device case comprising amorphous non-ferrous metal alloy material and having lower electrical conductivity than crystalline atomic structures comprising the same alloy constituents. The generation of eddy currents is thereby reduced and inductive charging and/or telemetry system operation can take place at higher frequencies with a resulting improvement in energy and data transfer efficiency.

Abstract translation: 可植入装置包括包含无定形有色金属合金材料并且具有比包含相同合金成分的结晶原子结构更低导电性的装置壳体。 从而降低了涡流的产生，并且可以在较高频率下进行感应充电和/或遥测系统操作，从而提高了能量和数据传输效率。

公开(公告)号：US07136701B2

公开(公告)日：2006-11-14

申请号：US10727349

申请日：2003-12-03

Applicant: Wilson Greatbatch ,  Jeffrey Deal

Inventor： Wilson Greatbatch ,  Jeffrey Deal

IPC: A61N1/40

CPC classification number: H01M16/00 ,  A61N1/08 ,  A61N1/378 ,  H01M6/16 ,  H01M6/5016 ,  H01M6/5033 ,  H01M10/052 ,  H01M10/0525 ,  H02J7/0054

Abstract: A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.

Abstract translation: 用于可植入医疗用途的混合电池电源在放电期间提供通常恒定的低内部电阻，并且避免由于Li / SVO电池的下降引起的电阻增加而发展的类型的电压延迟。 混合电池电源使用两个电池或电池，一个是相对较高能量密度的主电池，另一个是可再充电的内阻相对较低的二次电池。 主电池和次电池通过电压升压/充电控制电路以并联装置连接，该电压升压/充电控制电路由主电池供电并且适于对二次电池充电，同时以优化其高能量输出的方式限制充电/放电偏移 医疗器械使用。 混合电池电源所在的医疗装置的储能电容器由二次电池驱动。 主电池用作再次充电二次电池的能量源。

公开(公告)号：US20060111752A1

公开(公告)日：2006-05-25

申请号：US10994565

申请日：2004-11-22

Applicant: Wilson Greatbatch ,  Jeffrey Deal

Inventor： Wilson Greatbatch ,  Jeffrey Deal

IPC: A61N1/378

CPC classification number: A61N1/3975 ,  A61N1/3787 ,  H01M10/052 ,  H01M10/44 ,  H01M10/441 ,  H01M10/46

Abstract: A high energy battery power source suitable for use in an implantable medical device includes an input, an output, and two or more battery modules each comprising two or more battery cells. The battery cells are of relatively low voltage and permanently configured within each battery module in an electrically parallel arrangement in order to provide a desired current discharge level needed to achieve high-energy output. A switching system configures the battery modules between a first configuration wherein the battery modules are electrically connected in parallel to each other and to the input in order to receive charging energy at the relatively low voltage, and a second configuration wherein the battery modules are electrically connected in series to each other in order to provide to the output a relatively high voltage corresponding to the number of battery modules at a current level corresponding to the number of battery cells in a single battery module.

Abstract translation: 适用于可植入医疗装置的高能量电池电源包括输入端，输出端和两个或更多个电池模块，每个电池模块包括两个或多个电池单元。 电池单元具有相对低的电压并且以电并联的方式永久地配置在每个电池模块内，以便提供实现高能量输出所需的期望的电流放电水平。 交换系统将电池模块配置在第一配置之间，其中电池模块彼此并联电连接到输入端，以便在相对低的电压下接收充电能量;以及第二配置，其中电池模块电连接 彼此串联，以向输出提供对应于在单个电池模块中与电池单元的数量相对应的当前电平的电池模块的数量的相对高的电压。

公开(公告)号：US07020519B2

公开(公告)日：2006-03-28

申请号：US10407916

申请日：2003-04-04

Applicant: Wilson Greatbatch ,  Jeffrey Deal

Inventor： Wilson Greatbatch ,  Jeffrey Deal

IPC: A61N1/18

CPC classification number: H01M16/00 ,  A61N1/378 ,  H01M6/16 ,  H01M6/5016 ,  H01M6/5033 ,  H01M10/052 ,  H01M10/0525 ,  H02J7/0054

Abstract: A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.

公开(公告)号：US4314554A

公开(公告)日：1982-02-09

申请号：US57744

申请日：1979-07-16

Applicant: Wilson Greatbatch

Inventor： Wilson Greatbatch

IPC: A61N1/18 ,  A61B17/58 ,  A61F2/28 ,  A61N1/08 ,  A61N1/20 ,  A61N1/32 ,  A61N1/372 ,  A61N1/30

CPC classification number: A61B17/58 ,  A61N1/08 ,  A61N1/205 ,  A61N1/326 ,  A61N1/372 ,  A61F2002/2821

Abstract: A method and apparatus for providing germicidal and healing treatment of tissue such as bone wherein an electrode of silver or like material is applied to a living tissue site to be healed, initially a direct voltage is applied to the electrode of a polarity driving the electrode as an anode to release silver ions to create a germicidal environment at the site, and thereafter a direct voltage of opposite polarity is applied to the electrode driving it as a cathode to stimulate healing of the tissue at the site. The apparatus is implanted in the body of a patient, and in one embodiment a battery is connected through a switch to the electrode and a reference electrode, the switch initially connecting the electrode as an anode and thereafter changeable by an external operator such as a magnet to connect the electrode as a cathode. In another embodiment, another electrode and an element cooperate with the treating electrode to form a galvanic couple with the treating electrode to create a germicidal environment and a predetermined time thereafter the arrangement changes to a biogalvanic couple with body fluid to cause healing of the tissue. In either embodiment a wave shaping circuit can be operatively associated with the treating electrode to facilitate external monitoring of the apparatus when implanted.

Abstract translation: 一种用于提供诸如骨的组织的杀菌和愈合治疗的方法和装置，其中将银或类似材料的电极施加到待愈合的生物体组织部位，最初将直流电压施加到驱动电极的极性的电极，如 阳极以释放银离子以在该位置产生杀菌环境，之后将极性相反的直流电压施加到驱动其作为阴极的电极上，以刺激该部位组织的愈合。 该装置植入患者体内，在一个实施例中，电池通过开关连接到电极和参考电极，开关最初将电极连接为阳极，然后可由诸如磁体的外部操作者 将电极连接成阴极。 在另一个实施方案中，另一个电极和元件与处理电极配合，以与处理电极形成电偶，以产生杀菌环境，此后，预定时间将布置改变为与体液的生物金属联接，从而引起组织愈合。 在任一实施例中，波形整形电路可以与处理电极可操作地相关联，以便于在植入时对装置进行外部监测。